Placebo + RG7314
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Autism Spectrum Disorder
Conditions
Autism Spectrum Disorder
Trial Timeline
Sep 1, 2013 → Sep 1, 2016
NCT ID
NCT01793441About Placebo + RG7314
Placebo + RG7314 is a phase 2 stage product being developed by Roche for Autism Spectrum Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT01793441. Target conditions include Autism Spectrum Disorder.
What happened to similar drugs?
0 of 10 similar drugs in Autism Spectrum Disorder were approved
Approved (0) Terminated (2) Active (8)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01793441 | Phase 2 | Completed |
Competing Products
20 competing products in Autism Spectrum Disorder